Neutrophil-to-lymphocyte ratio but not monocyte-to-HDL cholesterol ratio nor platelet-to-lymphocyte ratio correlates with early stages of lower extremity arterial disease: an ultrasonographic study.

L Santoro, P M Ferraro, A Nesci, A D'Alessandro, N Macerola, F Forni, R Tartaglione, R De Vitis, A Gasbarrini, A Santoliquido

Journal: European review for medical and pharmacological sciences 2022;25(9):3453-3459

PMID: 34002838

Abstract

OBJECTIVE

The role of inflammatory markers as neutrophil-to-lymphocyte ratio (NLR), monocyte-to-high-density lipoprotein-cholesterol ratio (MHR), and platelet-to-lymphocyte ratio (PLR) in cardiovascular diseases has been widely investigated in recent years. In the context of lower extremity arterial disease (LEAD), this association has been mainly studied in the advanced stages. The aim of our study was to investigate the role of these inflammatory markers in all stages of LEAD, including early ones, using ultrasonography as diagnostic tool, together with ankle-brachial index (ABI) determination.

PATIENTS AND METHODS

In this cross-sectional observational study, we enrolled 240 patients undergoing ultrasonographic evaluation of the lower limb arteries and ABI determination because of symptoms suggestive of LEAD or presence of known cardiovascular risk factors.

RESULTS

In our study population, we found that ultrasonographic categories of LEAD were associated with NLR, but not with MHR and PLR.

CONCLUSIONS

These results confirm that a specific pattern of inflammation can be found in all stages of LEAD, including early ones.

Address: Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.